0001213900-24-028916.txt : 20240401
0001213900-24-028916.hdr.sgml : 20240401
20240401172153
ACCESSION NUMBER: 0001213900-24-028916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240327
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Exploration Capital, LLC
CENTRAL INDEX KEY: 0002003514
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 24811045
BUSINESS ADDRESS:
STREET 1: 250 EAST 200 SOUTH, FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
BUSINESS PHONE: (212) 220-4444
MAIL ADDRESS:
STREET 1: 250 EAST 200 SOUTH, FLOOR 16
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Brickell Biotech, Inc.
DATE OF NAME CHANGE: 20190830
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
4
1
marketforms-65426.xml
PRIMARY DOCUMENT
X0508
4
2024-03-27
0000819050
Fresh Tracks Therapeutics, Inc.
FRTX
0002003514
Exploration Capital, LLC
250 EAST 200 SOUTH, FLOOR 16
SALT LAKE CITY
UT
84111
false
false
true
false
0
Common Stock
2024-03-27
4
P
false
51634
0.90
A
1015773
D
Common Stock
2024-03-28
4
P
false
2586
0.90
A
1018359
D
Common Stock
2024-04-01
4
P
false
354
0.89
A
1018713
D
Common Stock
1018713
D
Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
These shares are directly owned by Stephen L. Gustin.
Stephen L. Gustin on behalf of Exploration Capital, LLC
2024-04-01